Pulmonary arterial hypertension | Familial pulmonary arterial hypertension | Pulmonary arterial hypertension Secondary to Systemic Scleroderma | Pulmonary Fibrosis Marked
Item
diagnosis of pah of either primary (idiopathic), familial or secondary to systemic sclerosis (excluding those with marked pulmonary fibrosis) according to world conference on pulmonary hypertension classification (venice, 2003).
boolean
C2973725 (UMLS CUI [1])
C1701939 (UMLS CUI [2])
C3665995 (UMLS CUI [3,1])
C0175668 (UMLS CUI [3,2])
C0036421 (UMLS CUI [3,3])
C0034069 (UMLS CUI [4,1])
C1706089 (UMLS CUI [4,2])
Symptoms WHO Pulmonary arterial hypertension Class Functional
Item
symptoms with a who class of ii-iv
boolean
C1457887 (UMLS CUI [1,1])
C0043237 (UMLS CUI [1,2])
C2973725 (UMLS CUI [1,3])
C0456387 (UMLS CUI [1,4])
C0205245 (UMLS CUI [1,5])
Phosphodiesterase Inhibitors | Pentoxifylline | Enoximone | Milrinone | pimobendan
Item
use of unspecific phosphodiesterase inhibitors (for example, pentoxyfillin, enoximon, milrinone or pimobendan) during the study
boolean
C0031638 (UMLS CUI [1])
C0030899 (UMLS CUI [2])
C0116190 (UMLS CUI [3])
C0128513 (UMLS CUI [4])
C0071071 (UMLS CUI [5])
Nitric oxide therapy Inhaled chronic
Item
chronic inhaled nitric oxide therapy from start to study completion
boolean
C1135474 (UMLS CUI [1,1])
C0001559 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
Catecholamines | Adrenalin | Norepinephrine | Dopamine
Item
treatment with catecholamines (for example, adrenalin, noradrenalin, dopamine),
boolean
C0007412 (UMLS CUI [1])
C1963284 (UMLS CUI [2])
C0028351 (UMLS CUI [3])
C0013030 (UMLS CUI [4])
Lung diseases Pre-existing | Parasitic Diseases Affecting Lungs | Asthma | Congenital anomaly of lung | Abnormality of the thorax Congenital | Abnormality of the diaphragm Congenital
Item
pre-existing lung diseases, including parasitic diseases affecting lungs, asthma, congenital abnormalities of the lungs, chest, and diaphragm.
boolean
C0024115 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C0030499 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0024109 (UMLS CUI [2,3])
C0004096 (UMLS CUI [3])
C0158644 (UMLS CUI [4])
C4021797 (UMLS CUI [5,1])
C1744681 (UMLS CUI [5,2])
C1848873 (UMLS CUI [6,1])
C1744681 (UMLS CUI [6,2])
Pulmonary artery stenosis | Pulmonary Valve Stenosis | Venous hypertension pulmonary | Chronic thromboembolic pulmonary hypertension
Item
pulmonary artery or valve stenosis; pulmonary venous hypertension; chronic thromboembolic pulmonary hypertension
boolean
C0238397 (UMLS CUI [1])
C0034089 (UMLS CUI [2])
C0340766 (UMLS CUI [3,1])
C0024109 (UMLS CUI [3,2])
C2363973 (UMLS CUI [4])
Heart failure | Chronic left-sided heart failure | Valvular disease Congenital | Valvular disease Acquired | Cardiomyopathy Congenital | Cardiomyopathy Acquired
Item
acute heart failure or chronic left sided heart failure; congenital or acquired valvular or myocardial disease
boolean
C0018801 (UMLS CUI [1])
C0264726 (UMLS CUI [2])
C3258293 (UMLS CUI [3,1])
C1744681 (UMLS CUI [3,2])
C3258293 (UMLS CUI [4,1])
C0439661 (UMLS CUI [4,2])
C0878544 (UMLS CUI [5,1])
C1744681 (UMLS CUI [5,2])
C0878544 (UMLS CUI [6,1])
C0439661 (UMLS CUI [6,2])
Hypertensive disease Severe | Systolic Pressure | Diastolic blood pressure | Clinical Trial Eligibility Criteria Study Protocol
Item
severe (systemic) arterial hypertension (> 200 mmhg (systolic) or > 120 mmhg (diastolic)) other protocol-defined inclusion/exclusion criteria may apply
boolean
C0020538 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
C1516637 (UMLS CUI [4,1])
C2348563 (UMLS CUI [4,2])